Literature DB >> 23775223

MHCcluster, a method for functional clustering of MHC molecules.

Martin Thomsen1, Claus Lundegaard, Søren Buus, Ole Lund, Morten Nielsen.   

Abstract

The identification of peptides binding to major histocompatibility complexes (MHC) is a critical step in the understanding of T cell immune responses. The human MHC genomic region (HLA) is extremely polymorphic comprising several thousand alleles, many encoding a distinct molecule. The potentially unique specificities remain experimentally uncharacterized for the vast majority of HLA molecules. Likewise, for nonhuman species, only a minor fraction of the known MHC molecules have been characterized. Here, we describe a tool, MHCcluster, to functionally cluster MHC molecules based on their predicted binding specificity. The method has a flexible web interface that allows the user to include any MHC of interest in the analysis. The output consists of a static heat map and graphical tree-based visualizations of the functional relationship between MHC variants and a dynamic TreeViewer interface where both the functional relationship and the individual binding specificities of MHC molecules are visualized. We demonstrate that conventional sequence-based clustering will fail to identify the functional relationship between molecules, when applied to MHC system, and only through the use of the predicted binding specificity can a correct clustering be found. Clustering of prevalent HLA-A and HLA-B alleles using MHCcluster confirms the presence of 12 major specificity groups (supertypes) some however with highly divergent specificities. Importantly, some HLA molecules are shown not to fit any supertype classification. Also, we use MHCcluster to show that chimpanzee MHC class I molecules have a reduced functional diversity compared to that of HLA class I molecules. MHCcluster is available at www.cbs.dtu.dk/services/MHCcluster-2.0.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23775223      PMCID: PMC3750724          DOI: 10.1007/s00251-013-0714-9

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  29 in total

1.  Identifiying human MHC supertypes using bioinformatic methods.

Authors:  Irini A Doytchinova; Pingping Guan; Darren R Flower
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

2.  NetMHCcons: a consensus method for the major histocompatibility complex class I predictions.

Authors:  Edita Karosiene; Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Immunogenetics       Date:  2011-10-20       Impact factor: 2.846

Review 3.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery.

Authors:  Claus Lundegaard; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunology       Date:  2010-05-26       Impact factor: 7.397

4.  HLArestrictor--a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides.

Authors:  Malene Erup Larsen; Henrik Kloverpris; Anette Stryhn; Catherine K Koofhethile; Stuart Sims; Thumbi Ndung'u; Philip Goulder; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2010-11-16       Impact factor: 2.846

5.  Identifying HLA supertypes by learning distance functions.

Authors:  Tomer Hertz; Chen Yanover
Journal:  Bioinformatics       Date:  2007-01-15       Impact factor: 6.937

6.  Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays.

Authors:  Mikkel Harndahl; Sune Justesen; Kasper Lamberth; Gustav Røder; Morten Nielsen; Søren Buus
Journal:  J Biomol Screen       Date:  2009-02-04

7.  Selection of representative protein data sets.

Authors:  U Hobohm; M Scharf; R Schneider; C Sander
Journal:  Protein Sci       Date:  1992-03       Impact factor: 6.725

8.  NetMHCpan, a method for MHC class I binding prediction beyond humans.

Authors:  Ilka Hoof; Bjoern Peters; John Sidney; Lasse Eggers Pedersen; Alessandro Sette; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2008-11-12       Impact factor: 2.846

9.  The immune epitope database 2.0.

Authors:  Randi Vita; Laura Zarebski; Jason A Greenbaum; Hussein Emami; Ilka Hoof; Nima Salimi; Rohini Damle; Alessandro Sette; Bjoern Peters
Journal:  Nucleic Acids Res       Date:  2009-11-11       Impact factor: 16.971

10.  NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence.

Authors:  Morten Nielsen; Claus Lundegaard; Thomas Blicher; Kasper Lamberth; Mikkel Harndahl; Sune Justesen; Gustav Røder; Bjoern Peters; Alessandro Sette; Ole Lund; Søren Buus
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

View more
  38 in total

1.  Improved methods for predicting peptide binding affinity to MHC class II molecules.

Authors:  Kamilla Kjaergaard Jensen; Massimo Andreatta; Paolo Marcatili; Søren Buus; Jason A Greenbaum; Zhen Yan; Alessandro Sette; Bjoern Peters; Morten Nielsen
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

2.  Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule.

Authors:  Michael Rasmussen; Mikkel Harndahl; Anette Stryhn; Rachid Boucherma; Lise Lotte Nielsen; François A Lemonnier; Morten Nielsen; Søren Buus
Journal:  J Immunol       Date:  2014-10-13       Impact factor: 5.422

3.  NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.

Authors:  Edita Karosiene; Michael Rasmussen; Thomas Blicher; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunogenetics       Date:  2013-07-31       Impact factor: 2.846

4.  Sequence diversity between class I MHC loci of African native and introduced Bos taurus cattle in Theileria parva endemic regions: in silico peptide binding prediction identifies distinct functional clusters.

Authors:  Isaiah Obara; Morten Nielsen; Marie Jeschek; Ard Nijhof; Camila J Mazzoni; Nicholas Svitek; Lucilla Steinaa; Elias Awino; Cassandra Olds; Ahmed Jabbar; Peter-Henning Clausen; Richard P Bishop
Journal:  Immunogenetics       Date:  2016-02-06       Impact factor: 2.846

5.  Deciphering complex patterns of class-I HLA-peptide cross-reactivity via hierarchical grouping.

Authors:  Sumanta Mukherjee; Jim Warwicker; Nagasuma Chandra
Journal:  Immunol Cell Biol       Date:  2015-02-24       Impact factor: 5.126

6.  Polymorphism analysis and supertype definition of swine leukocyte antigen class I molecules in three-way crossbred (Landrace, Duroc, and Yorkshire) pigs: implications for the vaccine development of African swine fever virus.

Authors:  Limin Ba; Zhenbao Wang; William J Liu; Dongxun Wu; Wangzhen Xiang; Peng Qi; Chunna Dong; Yanxin Hu; Ping Lu; Jin Xiao; Changyuan Yu
Journal:  Sci China Life Sci       Date:  2020-05-11       Impact factor: 6.038

7.  A modern approach for epitope prediction: identification of foot-and-mouth disease virus peptides binding bovine leukocyte antigen (BoLA) class I molecules.

Authors:  Mital Pandya; Michael Rasmussen; Andreas Hansen; Morten Nielsen; Soren Buus; William Golde; John Barlow
Journal:  Immunogenetics       Date:  2015-11       Impact factor: 2.846

8.  An in silico study to unveil potential drugs and vaccine chimera for HBV capsid assembly protein: combined molecular docking and dynamics simulation approach.

Authors:  Saba Ismail; Yasir Waheed; Sajjad Ahmad; Omar Ahsan; Sumra Wajid Abbasi; Khulah Sadia
Journal:  J Mol Model       Date:  2022-02-02       Impact factor: 1.810

9.  Use of "one-pot, mix-and-read" peptide-MHC class I tetramers and predictive algorithms to improve detection of cytotoxic T lymphocyte responses in cattle.

Authors:  Nicholas Svitek; Andreas Martin Hansen; Lucilla Steinaa; Rosemary Saya; Elias Awino; Morten Nielsen; Søren Buus; Vishvanath Nene
Journal:  Vet Res       Date:  2014-04-28       Impact factor: 3.683

10.  Clustering HLA class I superfamilies using structural interaction patterns.

Authors:  Sumitro Harjanto; Lisa F P Ng; Joo Chuan Tong
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.